If You Could Only Choose Five Psychotropic Medicines: Updating the Interagency Emergency Health Kit

• Mark van Ommeren ,

  * E-mail: vanommerenm@who.int

  Affiliation Department of Mental Health and Substance Abuse, World Health Organization (WHO), Geneva, Switzerland

  ⨯
• Corrado Barbui,

  Affiliation WHO Collaborating Centre for Research and Training in Mental Health, Department of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy

  ⨯
• Kaz de Jong,

  Affiliation Médecins Sans Frontières-Holland (MSF-H, Doctors without Borders-Holland), Amsterdam, The Netherlands

  ⨯
• Tarun Dua,

  Affiliation Department of Mental Health and Substance Abuse, World Health Organization (WHO), Geneva, Switzerland

  ⨯
• Lynne Jones,

  Affiliation International Medical Corps (IMC), Santa Monica, California, United States of America

  ⨯
• Pau Perez-Sales,

  Affiliation Medicos del Mundo España (MdM-E, Doctors of the World-Spain), Madrid, Spain

  ⨯
• Marian Schilperoord,

  Affiliation Senior Public Health Officer, Public Health and HIV Section, United Nations High Commissioner of Refugees (UNHCR), Geneva, Switzerland

  ⨯
• Peter Ventevogel,

  Affiliation HealthNet TPO, Amsterdam, The Netherlands

  ⨯
• M. Taghi Yasamy,

  Affiliation Department of Mental Health and Substance Abuse, World Health Organization (WHO), Geneva, Switzerland

  ⨯
• Shekhar Saxena

  Affiliation Department of Mental Health and Substance Abuse, World Health Organization (WHO), Geneva, Switzerland

  ⨯